Home » Topics » BioWorld Science

BioWorld Science
RSS

Actelion seeks FDA approval of Opsumit for inoperable chronic thromboembolic pulmonary hypertension

May 2, 2018

FDA approves Tafinlar + Mekinist for adjuvant treatment of BRAF V600-mutant melanoma

May 2, 2018

Hetero Labs divulges betulinic acid analogues for HIV infection

May 2, 2018

Lactobacillus reuteri may reduce bone loss in older women

May 2, 2018

Genocea files IND for phase I/IIa study of GEN-009

May 2, 2018

DKFZ patents novel KLK6 inhibitors

May 2, 2018

FDA approves Kymriah for relapsed or refractory large B-cell lymphoma

May 2, 2018

Spark Therapeutics sells priority review voucher to Jazz Pharmaceuticals

May 2, 2018

AbbVie submits European MAA for risankizumab in moderate to severe plaque psoriasis

May 2, 2018

FDA grants QIDP and fast track designations to oral SCY-078 for vulvovaginal candidiasis

May 2, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...